4//SEC Filing
Brege Laura 4
Accession 0001415889-25-015832
CIK 0001070494other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:01 PM ET
Size
5.1 KB
Accession
0001415889-25-015832
Insider Transaction Report
Form 4
Brege Laura
Director
Transactions
- Sale
Common Stock
2025-06-04$21.78/sh−14,446$314,634→ 15,095 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.77 through $21.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001365619
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:01 PM ET
- Size
- 5.1 KB